Lloyd D . Graham

Lloyd D . Graham

Auto-generated profile, based on publicly available information

Lloyd D . Graham

Sydney Laboratory

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Genes & Cancer
Verified
Journal Article
Open access
LGLloyd D. Graham
Lloyd D. Graham
SPSusanne K. Pedersen
Susanne K. Pedersen
GBGlenn S. Brown
Glenn S. Brown
THThu Ho
Thu Ho
ZKZena Kassir
Zena Kassir
PMPeter Molloy
Peter Molloy
An uncharacterized gene locus (Chr16:hCG_1815491), now named colorectal neoplasia differentially expressed (gene symbol CRNDE), is activated early in colorectal neoplasia. The locus is unrelated to any known protein-coding gene. Microarray analysis of 454 tissue specimens (discovery) and 68 previously untested specimens (validation) showed elevated expression of CRNDE in >90% of colorectal adenomas and adenocarcinomas. These findings were confirmed and extended by exon microarray studies and RT-PCR assays. CRNDE transcription start sites were identified in CaCo2 and HCT116 cells by 5′-RACE. The major transcript isoforms in colorectal cancer (CRC) cell lines and colorectal tissue are CRNDE-a, -b, -d, -e, -f, -h, and -j. Except for CRNDE-d, the known CRNDE splice variants are upregulated in neoplastic colorectal tissue; expression levels for CRNDE-h alone demonstrate a sensitivity of 95% and specificity of 96% for adenoma versus normal tissue. A quantitative RT-PCR assay measuring CRNDE-h RNA levels in plasma was (with a threshold of 2–ΔCt = 2.8) positive for 13 of 15 CRC patients (87%) but only 1 of 15 healthy individuals (7%). We conclude that individual CRNDE transcripts show promise as tissue and plasma biomarkers, potentially exhibiting high sensitivity and specificity for colorectal adenomas and cancers.

1 January 2012 in Frontiers in Genetics
Verified
Journal Article
Open access
BEBlake C. Ellis
Blake C. Ellis
PMPeter Molloy
Peter Molloy
LGLloyd D. Graham
Lloyd D. Graham
CRNDE is the gene symbol for Colorectal Neoplasia Differentially Expressed (non-protein-coding), a long non-coding RNA (lncRNA) gene that expresses multiple splice variants and displays a very tissue-specific pattern of expression. CRNDE was initially identified as a lncRNA whose expression is highly elevated in colorectal cancer, but it is also upregulated in many other solid tumors and in leukemias. Indeed, CRNDE is the most upregulated lncRNA in gliomas and here, as in other cancers, it is associated with a “stemness” signature. CRNDE is expressed in specific regions within the human and mouse brain; the mouse ortholog is high in induced pluripotent stem cells and increases further during neuronal differentiation. We suggest that CRNDE is a multifunctional lncRNA whose different splice forms provide specific functional scaffolds for regulatory complexes, such as the polycomb repressive complex 2 (PRC2) and CoREST chromatin-modifying complexes, which CRNDE helps pilot to target genes.

1 February 2014 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Open access
BEBlake C. Ellis
Blake C. Ellis
LGLloyd D. Graham
Lloyd D. Graham
PMPeter Molloy
Peter Molloy
Colorectal neoplasia differentially expressed (CRNDE) is a novel gene that is activated early in colorectal cancer but whose regulation and functions are unknown. CRNDE transcripts are recognized as long non-coding RNAs (lncRNAs), which potentially interact with chromatin-modifying complexes to regulate gene expression via epigenetic changes. Complex alternative splicing results in numerous transcripts from this gene, and we have identified novel transcripts containing a highly-conserved sequence within intron 4 ("gVC-In4"). In colorectal cancer cells, we demonstrate that treatment with insulin and insulin-like growth factors (IGF) repressed CRNDE nuclear transcripts, including those encompassing gVC-In4. These repressive effects were negated by use of inhibitors against either the PI3K/Akt/mTOR pathway or Raf/MAPK pathway, suggesting CRNDE is a downstream target of both signaling cascades. Expression array analyses revealed that siRNA-mediated knockdown of gVC-In4 transcripts affected the expression of many genes, which showed correlation with insulin/IGF signaling pathway components and responses, including glucose and lipid metabolism. Some of the genes are identical to those affected by insulin treatment in the same cell line. The results suggest that CRNDE expression promotes the metabolic changes by which cancer cells switch to aerobic glycolysis (Warburg effect). This is the first report of a lncRNA regulated by insulin/IGFs, and our findings indicate a role for CRNDE nuclear transcripts in regulating cellular metabolism which may correlate with their upregulation in colorectal cancer.

7 January 2013 in Annual Review of Entomology
Verified
Journal Article
Closed access
RHRonald J. Hill
Ronald J. Hill
Isabelle M.L. BillasIsabelle M.L. Billas
Isabelle M.L. Billas
FBFrançois Bonneton
François Bonneton
LGLloyd D. Graham
Lloyd D. Graham
MLMichael Lawrence
Michael Lawrence
In 1974, Ashburner and colleagues postulated a model to explain the control of the puffing sequence on Drosophila polytene chromosomes initiated by the molting hormone 20-hydroxyecdysone. This model inspired a generation of molecular biologists to clone and characterize elements of the model, thereby providing insights into the control of gene networks by steroids, diatomic gases, and other small molecules. It led to the first cloning of the EcR subunit of the heterodimeric EcR-USP ecdysone receptor. X-ray diffraction studies of the ligand-binding domain of the receptor are elucidating the specificity of receptor-ecdysteroid interactions, the selectivity of some environmentally friendly insecticides, the evolution of the EcR-USP heterodimer, and indeed Ashburner's classical biochemical evidence for the central role of the ecdysone receptor in his model.

1 April 1999 in Matrix Biology
Verified
Journal Article
Closed access
JWJohn Whitelock
John Whitelock
LGLloyd D. Graham
Lloyd D. Graham
JMJames Melrose
James Melrose
AMAlan D. Murdoch
Alan D. Murdoch
RIRenato V. Iozzo
Renato V. Iozzo
PUP. Anne Underwood
P. Anne Underwood

1 October 1985 in Journal of Molecular Biology
Verified
Journal Article
Closed access
JGJohn R. Guest
John R. Guest
HLHilary M. Lewis
Hilary M. Lewis
LGLloyd D. Graham
Lloyd D. Graham
LPLeonard C. Packman
Leonard C. Packman
RPRichard N. Perham
Richard N. Perham